Neff Thomas B

Avg. Two Year Performance

No purchase track record
(12%) Avg. Sale Return
(6%) Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return(< 1%)(2%)(6%)(10%)(12%)
Sale Success Rate24 of 4820 of 4824 of 4824 of 4822 of 48
Drugs » Biotechnology

Chief Executive Officer, Director:

Holdings: 2.45M shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--